Patent ID: 7816358

Claim:
A pharmaceutical formulation comprising at least one N,N′-disubstituted piperazine compound corresponding to formula I wherein R 1 and R 2 together form a (CH 2 ) n chain, wherein n represents an integer from 2-9; R 3 represents a linear or branched, saturated or unsaturated aliphatic C 1-3 radical, a saturated or unsaturated cycloaliphatic C 5-6 radical, a phenyl radical, or a five- or six-membered heteroaryl radical, wherein the ring system of R 3 is optionally mono- or polysubstituted with halogen, an alkyl group, an alkoxy group or a trihalogenated alkyl group and is optionally bonded via a linear or branched, saturated or unsaturated aliphatic C 1-3 bridge; and R 4 represents hydrogen or a phenyl radical; R 5 represents a linear or branched, saturated or unsaturated aliphatic C 1-3 radical or a phenyl radical optionally substituted with halogen or an alkoxy group; or a salt thereof with a physiologically acceptable acid; and optionally a physiologically acceptable auxiliary substance.